CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 242 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,853,016 | +16.5% | 178,125 | -4.9% | 0.00% | 0.0% |
| Q2 2023 | $4,165,734 | +0.5% | 187,224 | -2.2% | 0.00% | 0.0% |
| Q1 2023 | $4,146,244 | -0.7% | 191,424 | -6.9% | 0.00% | 0.0% |
| Q4 2022 | $4,175,005 | -20.7% | 205,564 | +0.1% | 0.00% | -33.3% |
| Q3 2022 | $5,267,000 | +7.9% | 205,408 | +0.0% | 0.00% | +50.0% |
| Q2 2022 | $4,883,000 | +3.3% | 205,329 | -2.2% | 0.00% | 0.0% |
| Q1 2022 | $4,728,000 | +1.6% | 209,955 | -10.6% | 0.00% | 0.0% |
| Q4 2021 | $4,652,000 | -31.4% | 234,941 | -31.9% | 0.00% | -33.3% |
| Q3 2021 | $6,786,000 | +27.9% | 344,804 | +43.0% | 0.00% | +50.0% |
| Q2 2021 | $5,306,000 | -9.9% | 241,194 | -2.6% | 0.00% | -33.3% |
| Q1 2021 | $5,889,000 | -8.5% | 247,534 | +0.6% | 0.00% | 0.0% |
| Q4 2020 | $6,439,000 | +50.3% | 246,134 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $4,284,000 | -6.7% | 246,134 | -9.9% | 0.00% | -33.3% |
| Q2 2020 | $4,593,000 | +42.0% | 273,040 | +0.4% | 0.00% | +50.0% |
| Q1 2020 | $3,234,000 | -1.0% | 272,020 | +0.7% | 0.00% | 0.0% |
| Q4 2019 | $3,268,000 | -16.7% | 270,070 | -2.7% | 0.00% | 0.0% |
| Q3 2019 | $3,924,000 | +16.6% | 277,620 | -8.0% | 0.00% | 0.0% |
| Q2 2019 | $3,365,000 | +10.5% | 301,770 | +16.4% | 0.00% | 0.0% |
| Q1 2019 | $3,044,000 | -12.1% | 259,270 | 0.0% | 0.00% | -33.3% |
| Q4 2018 | $3,464,000 | -4.7% | 259,270 | 0.0% | 0.00% | +50.0% |
| Q3 2018 | $3,635,000 | -54.6% | 259,270 | -49.1% | 0.00% | -66.7% |
| Q2 2018 | $8,006,000 | +118.7% | 509,270 | +128.9% | 0.01% | +100.0% |
| Q1 2018 | $3,660,000 | -18.2% | 222,510 | -10.2% | 0.00% | 0.0% |
| Q4 2017 | $4,473,000 | -11.0% | 247,690 | -4.9% | 0.00% | -25.0% |
| Q3 2017 | $5,025,000 | +42.6% | 260,360 | -12.8% | 0.00% | +33.3% |
| Q2 2017 | $3,523,000 | -7.8% | 298,540 | -14.4% | 0.00% | 0.0% |
| Q1 2017 | $3,822,000 | +30.7% | 348,680 | -13.5% | 0.00% | +50.0% |
| Q4 2016 | $2,925,000 | +12.4% | 402,940 | +0.7% | 0.00% | 0.0% |
| Q3 2016 | $2,602,000 | +113.5% | 400,240 | +79.2% | 0.00% | +100.0% |
| Q2 2016 | $1,219,000 | +251.3% | 223,320 | +201.0% | 0.00% | – |
| Q1 2016 | $347,000 | -6.2% | 74,200 | 0.0% | 0.00% | – |
| Q4 2015 | $370,000 | +28.5% | 74,200 | -3.3% | 0.00% | – |
| Q3 2015 | $288,000 | -38.7% | 76,700 | -1.9% | 0.00% | – |
| Q2 2015 | $470,000 | +20.2% | 78,200 | +12.0% | 0.00% | – |
| Q1 2015 | $391,000 | +88.9% | 69,800 | +1.0% | 0.00% | – |
| Q4 2014 | $207,000 | +11.9% | 69,100 | 0.0% | 0.00% | – |
| Q3 2014 | $185,000 | -4.1% | 69,100 | 0.0% | 0.00% | – |
| Q2 2014 | $193,000 | -43.1% | 69,100 | -11.1% | 0.00% | – |
| Q1 2014 | $339,000 | +29.4% | 77,700 | -4.7% | 0.00% | – |
| Q4 2013 | $262,000 | +56.9% | 81,500 | -22.3% | 0.00% | – |
| Q3 2013 | $167,000 | -10.7% | 104,900 | -3.0% | 0.00% | – |
| Q2 2013 | $187,000 | – | 108,107 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,712,176 | $123,147,000 | 6.01% |
| TANAKA CAPITAL MANAGEMENT INC | 74,139 | $1,048,000 | 3.38% |
| S&T BANK/PA | 625,078 | $8,859,000 | 1.92% |
| Parallel Advisors, LLC | 1,277,851 | $18,062,000 | 1.55% |
| AJ WEALTH STRATEGIES, LLC | 595,828 | $8,422,000 | 1.11% |
| Matarin Capital Management, LLC | 891,636 | $12,603,000 | 0.95% |
| Capital Impact Advisors, LLC | 162,544 | $2,370,000 | 0.90% |
| AMI ASSET MANAGEMENT CORP | 775,685 | $10,964,000 | 0.57% |
| Birchview Capital, LP | 50,000 | $707,000 | 0.47% |
| Zebra Capital Management LLC | 25,409 | $359,000 | 0.39% |